Granules India’s Vizag facility completes US FDA inspection with zero 483 observations
This facility manufactures APIs and formulations of oncology and non-oncology products
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Visakhapatnam
Lee Pharma to launch favipiravir under brand name Faravir at Rs 27 per tablet
It has got DCGI nod to manufacture and market favipiravir APIs
Ajinomoto Bio-Pharma expands small molecule manufacturing capabilities in India
The new 8,500 sq metre facility in Visakhapatnam is expected to be completed mid-2022
Natco Pharma gets USFDA approval for Visakhapatnam facility
The company did not disclose the product approved by the USFDA to be produced from the facility
Divi’s Laboratories begins commercial production at Visakhapatnam unit
The unit of the company is located at Chippada village, Bheemunipatnam Mandal Drug firm Divi's Laboratories said it has begun…
Laurus Labs receives EIR from US FDA for Visakhapatnam units
The company has also received approval from the Global Fund (GF) expert review panel for its fixed dose combination, TLE 400, for…